1 Study Coverage 1.1 Diabetic Neurological Disorder Therapeutic Drug Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Introduction 1.2 Global Diabetic Neurological Disorder Therapeutic Drug Outlook 2017 VS 2022 VS 2028 1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size for the Year 2017-2028 1.2.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size for the Year 2017-2028 1.3 Diabetic Neurological Disorder Therapeutic Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Diabetic Neurological Disorder Therapeutic Drug in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Diabetic Neurological Disorder Therapeutic Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics 1.4.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends 1.4.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers 1.4.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges 1.4.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Diabetic Neurological Disorder Therapeutic Drug by Type 2.1 Diabetic Neurological Disorder Therapeutic Drug Market Segment by Type 2.1.1 Capsule 2.1.2 Pills 2.1.3 Other 2.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017, 2022 & 2028) 2.3 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2028) 2.4 United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017, 2022 & 2028) 2.5 United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2028) 3 Diabetic Neurological Disorder Therapeutic Drug by Application 3.1 Diabetic Neurological Disorder Therapeutic Drug Market Segment by Application 3.1.1 Symmetrical Neuropathy 3.1.2 Focal and Multifocal Neuropathy 3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017, 2022 & 2028) 3.3 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2028) 3.4 United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017, 2022 & 2028) 3.5 United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2028) 4 Global Diabetic Neurological Disorder Therapeutic Drug Competitor Landscape by Company 4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Company 4.1.1 Top Global Diabetic Neurological Disorder Therapeutic Drug Companies Ranked by Revenue (2021) 4.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Player (2017-2022) 4.2 Global Diabetic Neurological Disorder Therapeutic Drug Concentration Ratio (CR) 4.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Diabetic Neurological Disorder Therapeutic Drug in 2021 4.2.3 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Diabetic Neurological Disorder Therapeutic Drug Headquarters, Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Type 4.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Headquarters and Area Served 4.3.2 Global Diabetic Neurological Disorder Therapeutic Drug Companies Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Diabetic Neurological Disorder Therapeutic Drug Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Company 4.5.1 Top Diabetic Neurological Disorder Therapeutic Drug Players in United States, Ranked by Revenue (2021) 4.5.2 United States Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2020, 2021 & 2022) 5 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region 5.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2028) 5.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2017-2022 5.2.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2017-2028 6.1.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2017-2028 6.3.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2017-2028 6.4.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 AstraZeneca 7.1.1 AstraZeneca Company Details 7.1.2 AstraZeneca Business Overview 7.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction 7.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.1.5 AstraZeneca Recent Development 7.2 Johnson & Johnson 7.2.1 Johnson & Johnson Company Details 7.2.2 Johnson & Johnson Business Overview 7.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction 7.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.2.5 Johnson & Johnson Recent Development 7.3 Takeda 7.3.1 Takeda Company Details 7.3.2 Takeda Business Overview 7.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction 7.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.3.5 Takeda Recent Development 7.4 Mitsubishi Chemical 7.4.1 Mitsubishi Chemical Company Details 7.4.2 Mitsubishi Chemical Business Overview 7.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction 7.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.4.5 Mitsubishi Chemical Recent Development 7.5 Avanir Pharmaceuticals 7.5.1 Avanir Pharmaceuticals Company Details 7.5.2 Avanir Pharmaceuticals Business Overview 7.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction 7.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.5.5 Avanir Pharmaceuticals Recent Development 7.6 Dong-A Pharmaceutical Co., Ltd. 7.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details 7.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview 7.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction 7.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Development 7.7 Immune Pharmaceuticals 7.7.1 Immune Pharmaceuticals Company Details 7.7.2 Immune Pharmaceuticals Business Overview 7.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction 7.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.7.5 Immune Pharmaceuticals Recent Development 7.8 MediciNova 7.8.1 MediciNova Company Details 7.8.2 MediciNova Business Overview 7.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction 7.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.8.5 MediciNova Recent Development 7.9 Sangamo BioSciences 7.9.1 Sangamo BioSciences Company Details 7.9.2 Sangamo BioSciences Business Overview 7.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction 7.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) 7.9.5 Sangamo BioSciences Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Diabetic Neurological Disorder Therapeutic Drug Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Diabetic Neurological Disorder Therapeutic Drug Market Trends Table 3. Diabetic Neurological Disorder Therapeutic Drug Market Drivers Table 4. Diabetic Neurological Disorder Therapeutic Drug Market Challenges Table 5. Diabetic Neurological Disorder Therapeutic Drug Market Restraints Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Diabetic Neurological Disorder Therapeutic Drug Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Player, 2017-2022 Table 13. Global Diabetic Neurological Disorder Therapeutic Drug Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Diabetic Neurological Disorder Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2021) Table 15. Top Players of Diabetic Neurological Disorder Therapeutic Drug in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Diabetic Neurological Disorder Therapeutic Drug Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Diabetic Neurological Disorder Therapeutic Drug Players in United States Market, Ranking by Revenue (2021) Table 20. United States Diabetic Neurological Disorder Therapeutic Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Diabetic Neurological Disorder Therapeutic Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Diabetic Neurological Disorder Therapeutic Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Diabetic Neurological Disorder Therapeutic Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 30. AstraZeneca Company Details Table 31. AstraZeneca Business Overview Table 32. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Table 33. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 34. AstraZeneca Recent Development Table 35. Johnson & Johnson Company Details Table 36. Johnson & Johnson Business Overview Table 37. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Table 38. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 39. Johnson & Johnson Recent Development Table 40. Takeda Company Details Table 41. Takeda Business Overview Table 42. Takeda Diabetic Neurological Disorder Therapeutic Drug Product Table 43. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 44. Takeda Recent Development Table 45. Mitsubishi Chemical Company Details Table 46. Mitsubishi Chemical Business Overview Table 47. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Table 48. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 49. Mitsubishi Chemical Recent Development Table 50. Avanir Pharmaceuticals Company Details Table 51. Avanir Pharmaceuticals Business Overview Table 52. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Table 53. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 54. Avanir Pharmaceuticals Recent Development Table 55. Dong-A Pharmaceutical Co., Ltd. Company Details Table 56. Dong-A Pharmaceutical Co., Ltd. Business Overview Table 57. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Table 58. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 59. Dong-A Pharmaceutical Co., Ltd. Recent Development Table 60. Immune Pharmaceuticals Company Details Table 61. Immune Pharmaceuticals Business Overview Table 62. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Table 63. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 64. Immune Pharmaceuticals Recent Development Table 65. MediciNova Company Details Table 66. MediciNova Business Overview Table 67. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Table 68. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 69. MediciNova Recent Development Table 70. Sangamo BioSciences Company Details Table 71. Sangamo BioSciences Business Overview Table 72. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Table 73. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million) Table 74. Sangamo BioSciences Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Diabetic Neurological Disorder Therapeutic Drug Product Picture Figure 2. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Diabetic Neurological Disorder Therapeutic Drug Market Size 2017-2028 (US$ Million) Figure 4. United States Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Diabetic Neurological Disorder Therapeutic Drug Market Size 2017-2028 (US$ Million) Figure 6. United States Diabetic Neurological Disorder Therapeutic Drug Market Share in Global 2017-2028 Figure 7. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered Figure 8. Product Picture of Capsule Figure 9. Product Picture of Pills Figure 10. Product Picture of Other Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type in 2022 & 2028 Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028) Figure 14. United States Diabetic Neurological Disorder Therapeutic Drug Market Share by Type in 2022 & 2028 Figure 15. United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028) Figure 17. Product Picture of Symmetrical Neuropathy Figure 18. Product Picture of Focal and Multifocal Neuropathy Figure 19. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application in 2022 & 2028 Figure 20. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028) Figure 22. United States Diabetic Neurological Disorder Therapeutic Drug Market Share by Application in 2022 & 2028 Figure 23. United States Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028) Figure 25. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 55. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 56. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 57. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 58. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 59. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 60. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 61. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

AstraZeneca Johnson & Johnson Takeda Mitsubishi Chemical Avanir Pharmaceuticals Dong-A Pharmaceutical Co., Ltd. Immune Pharmaceuticals MediciNova Sangamo BioSciences